FDA Approves Therapy To Treat Gaucher Disease
Links shared publicly online about this topic.
- 1,351total visits
FDA Approves Therapy To Treat Gaucher Disease
View full resource at tweetmeme.com
Tags: Genetic, Lipid Storage Disease, Gaucher Disease, Disease and Condition, Drug, Children's Health, FDA
Most Recently Shared on February 27, 2010 at 2:49 pm By:
FDA Approves Therapy To Treat Gaucher Disease http://retwt.me/1MjGN (via @healthytweet)
FDA Approves New GERD Treatment - Physician's First Watch
firstwatch.jwatch.org — “The FDA has approved a new device to treat symptoms of gastroesophageal reflux disease in patients who have not responded to traditional medical therapy. The LINX Reflux Management System is a surgically-placed string of magnetic . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 24, 2012 at 6:05 pm By:
Ves Dimov, M.D. Internist, Allergist, Physician, and Doctor
FDA Approves New GERD Treatment - surgically-placed string of magnetic titanium beads in lower esophageal sphincter http://t.co/2N84SPLu
FDA OKs Implant to Treat GERD - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved a surgically-implanted device for the treatment of gastroesophageal reflux disease (GERD) for patients whose symptoms persist despite use of maximum lifestyle and medical therapy.” View full resource at qualitypointtech.net
Most Recently Shared on March 23, 2012 at 7:00 pm By:
FDA OKs Implant to Treat GERD: WASHINGTON (MedPage Today) -- The FDA has approved a surgically-implanted device fo... http://t.co/4wvEUi8M
FDA approves LINX Reflux Management System to treat gastroesophageal reflux disease
fda.gov — “The Food and Drug Administration today approved the LINX Reflux Management System for people diagnosed with gastroesophageal reflux disease (GERD) who continue to have chronic symptoms, despite the use of maximum medical therapy for the treatment of reflux.” View full resource at fda.gov
Most Recently Shared on March 22, 2012 at 9:12 pm By:
eyeonfda Pharma and Health Lawyer
#FDA approves new #medicaldevice to treat #GERD http://t.co/P7jhY8wS
Arrival of direct antiviral agent therapy for hepatitis C sparks debate of who to treat first
sciencedaily.com — “For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, and with that clinicians must now decide who should be the first to receive this treatment. Discussion of this timely topic is covered in a new article.” View full resource at sciencedaily.com
Most Recently Shared on May 26, 2011 at 11:40 pm By:
Health Literacy Medical School
Arrival of Direct Antiviral Agent Therapy for #Hepatitis C Sparks Debate of Who to Treat First http://ht.ly/53ibc #HCV
New Targets Found for Aggressive Breast Cancer | Bioscience Technology Online
biosciencetechnology.com — “With currently available early-detection methods for breast cancer, many people can be treated successfully. But for the 20 percent of patients with so-called triple-negative breast cancer, the outcome is bleak. Now, however, researchers from Harvard Medical School and Baylor College of Medicine have identified a critical molecular component to the disease, one that suggests potential therapies involving combinations of FDA-approved, readily available drugs.” View full resource at biosciencetechnology.com
Most Recently Shared on March 24, 2011 at 3:25 pm By:
Men For A Cause (TM) Health Organization
New Targets Found for Aggressive Breast Cancer http://ping.fm/GvBVg
New Lupus Therapy Approval Coincides With Autoimmune Diseases Awareness Month
medicalnewstoday.com — “The Food and Drug Administration (FDA) approved Benlysta® (belimumab), a new biologic therapy developed to treat patients suffering from active, autoantibody-positive systemic lupus erythemato” View full resource at medicalnewstoday.com
Most Recently Shared on March 12, 2011 at 9:05 am By:
New Lupus Therapy Approval Coincides With Autoimmune Diseases Awareness Month http://mnt.to/3Sdc #vaccines #immunesystem
Lupus Foundation: FDA Clears First Lupus Drug Since 1955 - QualityPoint Technologies
qualitypointtech.net — “This week, after 56 years, the Food and Drug Administration (FDA) approved Benlysta (belimumab), to treat patients who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs. Lupus is a serious, potentially fatal, autoimmune disease that attacks healthy tissues. It disproportionately affects women, and usually develops between ages 15 and 44. Plaquenil (hydroxychloroquine) and corticosteroids, were approved in 1955. ” View full resource at qualitypointtech.net
Most Recently Shared on March 10, 2011 at 4:35 pm By:
Lupus Foundation: FDA Clears First Lupus Drug Since 1955: This week, after 56 years, the Food and Drug Administrat... http://bit.ly/i45V1F
Medical News: FDA Says No to Gaucher Drug - in Genetics, Genetics from MedPage Today
medpagetoday.com — “The FDA declined to approve a new replacement therapy for Gaucher disease, citing inadequate data on the drug's clinical performance and manufacturing controls, according to its manufacturer.” View full resource at medpagetoday.com
Most Recently Shared on February 25, 2011 at 6:11 pm By:
FDA Says No to Gaucher Drug http://bit.ly/eBCYzR
U.S. seeks more data on Protalix drug; shares sink | Reuters
reuters.com — “WASHINGTON (Reuters) - Health regulators want more data on Protalix Biotherapeutics Inc and Pfizer Inc's experimental drug for Gaucher disease before deciding whether to approve the therapy for patients” View full resource at reuters.com
Most Recently Shared on February 25, 2011 at 2:00 pm By:
FDA wants more data on Pfizer-Protalix drug: CHICAGO (Reuters) - U.S. health regulators have asked... http://bit.ly/ij4khQ #health #news
A Closer Look: Stem cells to help macular degeneration - latimes.com
latimes.com — “The FDA has given a green light to a Santa Monica company to treat children with a rare form of the eye disease. Success could lead to wider trials that could bring hope to those facing blindness.” View full resource at latimes.com
Most Recently Shared on January 11, 2011 at 9:43 pm By:
Stem cell therapy for macular degeneration: The FDA has approved a new study aimed at fighting dry age-related m... http://bit.ly/e4SR3U
Halaven Approved for Late-Stage Breast Cancer
businessweek.com — “Injected therapy believed to stifle cancer cell growth” View full resource at businessweek.com
Most Recently Shared on November 16, 2010 at 12:25 am By:
Halaven Approved for Late-Stage Breast Cancer http://goo.gl/1rYSD
Shire receives approval for VPRIV to treat type 1 Gaucher disease
news-medical.net — “Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on August 27, 2010 at 10:15 am By:
Shire receives approval for VPRIV to treat type 1 Gaucher disease: Shire, the global specialty biopharmaceutical c... http://bit.ly/d0YvUf
Oral therapy for Gaucher disease: Study yields positive results
sciencedaily.com — “Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a new study, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.” View full resource at sciencedaily.com
Most Recently Shared on May 3, 2010 at 9:30 pm By:
Oral therapy for Gaucher disease: Study yields positive results: Gaucher disease, a rare enzyme deficiency disorde... http://bit.ly/bEUKir
FDA Approves VPRIV to Treat Gaucher Disease
drugs.com — “VPRIV (velaglucerase alfa) is used to treat Gaucher disease. Includes VPRIV side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 5:02 am By:
FDA Approves VPRIV to Treat Gaucher Disease - http://bit.ly/dATgn7
Replacement Therapy Approved for Gaucher Disease - Drugs.com MedNews
drugs.com — “Velaglucerase alfa for injection (VPRIV) has been approved by the U.S. Food and Drug Administration to treat a rare inherited disorder called Gaucher disease, t” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 4:29 am By:
Replacement Therapy Approved for Gaucher Disease - http://bit.ly/9m1onF
Advertisement
